These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 22789393

  • 1. Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors.
    Morsch M, Reddel SW, Ghazanfari N, Toyka KV, Phillips WD.
    Exp Neurol; 2012 Oct; 237(2):286-95. PubMed ID: 22789393
    [Abstract] [Full Text] [Related]

  • 2. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN, Reddel SW, Gervásio OL, Phillips WD.
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [Abstract] [Full Text] [Related]

  • 3. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R, Plomp JJ, Huijbers MG, Niks EH, Straasheijm KR, Detmers FJ, Hermans PW, Sleijpen K, Verrips A, Losen M, Martinez-Martinez P, De Baets MH, van der Maarel SM, Verschuuren JJ.
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [Abstract] [Full Text] [Related]

  • 4. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.
    Viegas S, Jacobson L, Waters P, Cossins J, Jacob S, Leite MI, Webster R, Vincent A.
    Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis.
    Ghazanfari N, Morsch M, Tse N, Reddel SW, Phillips WD.
    PLoS One; 2014 Apr; 9(2):e87840. PubMed ID: 24505322
    [Abstract] [Full Text] [Related]

  • 16. Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes.
    Richman DP, Nishi K, Morell SW, Chang JM, Ferns MJ, Wollmann RL, Maselli RA, Schnier J, Agius MA.
    Arch Neurol; 2012 Apr; 69(4):453-60. PubMed ID: 22158720
    [Abstract] [Full Text] [Related]

  • 17. Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
    Phillips WD, Christadoss P, Losen M, Punga AR, Shigemoto K, Verschuuren J, Vincent A.
    Exp Neurol; 2015 Aug; 270():29-40. PubMed ID: 25542979
    [Abstract] [Full Text] [Related]

  • 18. [Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].
    Ohta R, Motomura M.
    Rinsho Byori; 2014 Mar; 62(3):255-60. PubMed ID: 24800501
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.